Author

Rebecca A. Leonard

Duke UniversityORCID 0000-0002-3404-0399Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alireza Rahimi· 1 shared Amal Gebara-LambiD· 1 shared Anil K. Sen GuptaiD· 1 shared Anshul Chaudhary· 1 shared Appaso Mahadev JadhaviD· 1 shared Arnab K. ChatterjeeiD· 1 shared Ashley K. Woods· 1 shared Briana Lynn McGoverniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alireza Rahimi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pan-Coronavirus Protease Engagement and Differentiated Pharmacology of Antiviral Candidate CMX990

N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva, Malina A. Bakowski, Simeon Babarinde, Anshul Chaudhary, Mark Zeller, Ashley K. Woods, Gennadii A. Grabovyi, Katy B. Wilson, Rebecca A. Leonard, Briana Lynn McGovern, Jared Benjamin, Isidora D. Suazo, Mary Gordon, , Arnab K. Chatterjee

This study evaluates CMX990, a coronavirus Mpro inhibitor, showing broad antiviral activity against multiple coronaviruses and superior pharmacologic properties compared to existing inhibitors.

bioRxiv · Oct 1, 2026 · PreprintPharmacology & Toxicology